Hinge Health (HNGE) Reiterated at Buy by Stifel After Addition of Surgical Option
Tweet Send to a Friend
Stifel analyst David Grossman reiterated a Buy rating and $79.00 price target on Hinge Health Inc (NYSE: HNGE).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
